Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
08/16/2011 | CA2496731C Novel benzonaphthyridines |
08/16/2011 | CA2493041C Injectable pharmaceutical composition for treating post-operative joint pain comprising an amide local anesthetic |
08/16/2011 | CA2487095C Elongase genes and uses thereof |
08/16/2011 | CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
08/11/2011 | WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
08/11/2011 | WO2011096642A2 Pharmaceutical composition for preventing and treating inflammatory diseases |
08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
08/11/2011 | WO2011096377A1 Pyrrole compound |
08/11/2011 | WO2011095021A1 Use of black soybean seedcoat extracts in manufacture of products for preventing and treating osteoarthritis |
08/11/2011 | WO2011038230A3 Compositions and methods for the prevention and treatment of metabolic diseases |
08/11/2011 | US20110196502 Methods of Using Water-Soluble Inorganic Compounds for Implants |
08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
08/11/2011 | US20110196035 Temporally-Controlled Treatment of Joint Disease |
08/11/2011 | US20110196024 Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases |
08/11/2011 | US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes |
08/11/2011 | US20110196009 INHIBITORS OF Akt ACTIVITY |
08/11/2011 | US20110196007 Monocyclic cyanoenones and methods of use thereof |
08/11/2011 | US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
08/11/2011 | US20110196002 Diacylglycerol acyltransferase inhibitors |
08/11/2011 | US20110195992 New compounds ii |
08/11/2011 | US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists |
08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
08/11/2011 | US20110195951 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
08/11/2011 | US20110195936 Bicyclic sphingosine 1-phosphate analogs |
08/11/2011 | US20110195935 Nitric oxide releasing amino acid ester compound, composition and method of use |
08/11/2011 | US20110195926 Purified beta glucan composition |
08/11/2011 | US20110195906 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
08/11/2011 | US20110195905 Apls for treating arthritis |
08/11/2011 | US20110195900 Peptidic pth receptor agonists |
08/11/2011 | US20110195899 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid |
08/11/2011 | US20110195453 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
08/11/2011 | US20110195114 Transdermal delivery systems for active agents |
08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
08/11/2011 | US20110195076 Therapeutic agent |
08/11/2011 | US20110195061 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha |
08/11/2011 | US20110195052 Bone matrix compositions and methods |
08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
08/11/2011 | US20110195022 Cd20 antibodies and uses thereof |
08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
08/11/2011 | CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
08/10/2011 | EP2353599A1 8-hydroxyquinolines as inhibitors of cathepsin B |
08/10/2011 | EP2353597A1 Arene chromium-carbonyl complexes, method for their preparation of and use thereof as pharmaceuticals |
08/10/2011 | EP2352727A1 Trpv1 antagonists |
08/10/2011 | EP2352726A1 Trpv1 antagonists |
08/10/2011 | EP2352501A1 Compounds for the treatment of osteoporosis and cancers |
08/10/2011 | EP1830853B1 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
08/10/2011 | EP1509617B1 Light emitting microorganisms and viruses for diagnosis of diseases associated with wounded or inflamed tissue |
08/10/2011 | EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
08/10/2011 | EP1411967B1 Blocking peptide for inflammatory cell secretion |
08/10/2011 | EP1358206B1 Peptide-based compounds |
08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
08/10/2011 | CN102149709A Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1H-pyrazole methanesulfonate and methods for their preparation |
08/10/2011 | CN102149688A New benzimidazole derivatives |
08/10/2011 | CN102149394A Methods of use of eggshell polypeptides |
08/10/2011 | CN102149381A A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
08/10/2011 | CN102149375A Human Beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
08/10/2011 | CN102146411A Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament |
08/10/2011 | CN102146074A Preparation method of pyrrole derivative and application thereof |
08/10/2011 | CN102145174A Chondroitin sulfate nano-selenium and preparation method thereof |
08/10/2011 | CN102145149A Plaster for treating arthralgia and myalgia |
08/10/2011 | CN102145142A Application of preparation for dispelling turbidity and dissipating blood stasis in preparation of medicaments for treating gouty arthritis |
08/10/2011 | CN102145141A Application of matching medicament to preparation of medicaments for treating chronic gout with gouty tophus |
08/10/2011 | CN102145136A Chinese medical meridian physiotherapy liquid and preparation method and application thereof |
08/10/2011 | CN102145127A Medicament for treating rheumatoid arthritis and preparation method thereof |
08/10/2011 | CN102145106A Chinese medical composition for treating osteoporosis and granular formulation capable of tonifying kidney and invigorating blood circulation |
08/10/2011 | CN102145100A Special oral preparation for treating cervical spondylosis |
08/10/2011 | CN102145058A Medicine preparation for preventing and treating asthenia cold for cattle |
08/10/2011 | CN102145043A Medicinal composition for treating cardiovascular diseases, and preparation and preparation method thereof |
08/10/2011 | CN102145040A Technique for adsorbing and extracting effective part of folium orthosiphoni by employing macroporous resin |
08/10/2011 | CN102145010A Use of combination of potassium and magnesium for preparing medicine for preventing or treating gout |
08/10/2011 | CN102144982A Minodronate tablets and preparation method thereof |
08/10/2011 | CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
08/10/2011 | CN101732522B Plaster for treating osteonecrosis of the femoral head, osseous tuberculosis, osteomyelitis and osteoma |
08/10/2011 | CN101693056B External medicine bag for treating articular osteoid diseases and using method thereof |
08/10/2011 | CN101606994B Plaster for treating bone rheumatism |
08/10/2011 | CN101507768B Qiwei dan capable of treating arthralgia due to wind cold dampness |
08/10/2011 | CN101502544B Capparis spinosa extract and capparis spinosa emulsifiable paste and method for producing the same |
08/10/2011 | CN101385812B Traditional Chinese medicine composition containing epimeddium for treating dermatomyositis and preparation thereof |
08/10/2011 | CN101380362B Quality control method of volatile ingredients fingerprint of bone knitting medicine of traumatology |
08/10/2011 | CN101297854B Plaster for curing lumbar and cervical vertebra diseases |
08/10/2011 | CN101269211B Shuangtang high calcium medicinal granule and preparation technique |
08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
08/09/2011 | US7994299 Compositions and methods for increasing bone mineralization |
08/09/2011 | US7994282 Card proteins involved in cell death regulation |
08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
08/09/2011 | US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
08/09/2011 | US7994134 Peptide-based compounds |
08/09/2011 | US7993878 Antibodies to human IL-1β |
08/09/2011 | US7993678 Hyaluronic acid derivatives |
08/09/2011 | CA2512000C Selective estrogen receptor modulator |